Shihua Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shihua Sun has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Anna-Lena B.G. Vigil
School of Life Sciences, University of Nevada, Las Vegas, USA
121 shared publications - Bulathsinhalage Gayani Kanchana Perera
Department of Chemistry, University of Washington, Seattle, Washington. 3
121 shared publications - Cynthia C.T. Sprenger
University of Washington, Seattle, WA
121 shared publications - Dustin J. Maly
Department of Chemistry, University of Washington, Seattle, WA, USA
121 shared publications - Grant R. Whitman
Department of Medicine, Division of Allergy and Infectious Disease, Center for Emerging and Reemerging Infectious Disease (CERID), University of Washington, Seattle, Washington, USA
121 shared publications - Haley J. Pang
University of Washington School of Medicine, Seattle, WA
121 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S11 from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Figure S11 shows glucose uptake assays.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S11 from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Figure S11 shows glucose uptake assays.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Figure S7 shows Western blot analysis confirming the findings with RPPA.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Figure S7 shows Western blot analysis confirming the findings with RPPA.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S4 from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Table S4 shows screening results of BKIDCs tested at 10 µM in LNCaP95 and PC3 cells in the MTS assay.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Table S4 shows screening results of BKIDCs tested at 10 µM in LNCaP95 and PC3 cells in the MTS assay.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S7 from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Table S7 shows pharmacokinetic parameters after a single dose in mouse, rat, dog, and cynomolgus monkey.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S7 from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Table S7 shows pharmacokinetic parameters after a single dose in mouse, rat, dog, and cynomolgus monkey.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S3 from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Table S3 shows PrP and PP-based BKIDC chemical structures.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Table S3 shows PrP and PP-based BKIDC chemical structures.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Figure S1 shows evaluation of Hexokinase activity using LNCaP crude extracts and recombinant enzyme.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Figure S1 shows evaluation of Hexokinase activity using LNCaP crude extracts and recombinant enzyme.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S6 from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Table S6 shows in vitro AMPK activity.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Table S6 shows in vitro AMPK activity.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Figure S3 shows competitive proteomic profiling of 1553-N-Me.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Figure S3 shows competitive proteomic profiling of 1553-N-Me.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Image from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Supplementary Image shows uncropped Western blot images.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Image from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Supplementary Image shows uncropped Western blot images.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S2 from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Table S2 shows rat cardiovascular assessment (nonGLP) after IV administration of increasing dosages of BKIDC-1553.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer
Table S2 shows rat cardiovascular assessment (nonGLP) after IV administration of increasing dosages of BKIDC-1553.